1.
LDL-cholesterol concentrations: a genome-wide association study
by Sandhu, Manjinder S, Dr
The Lancet (British edition), 2008, Vol.371 (9611), p.483-491

2.
Insulin receptor substrate-1 gene and cardiovascular risk factors in NIDDM
by Grant, PeterJ
The Lancet (British edition), 1995-09-23, Vol.346 (8978), p.841-842

4.
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase...
by Greenberg, Barry, Prof
The Lancet (British edition), 2016-03-19, Vol.387 (10024), p.1178-1186

5.
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses
by Ripatti, Samuli, Dr
The Lancet (British edition), 2010, Vol.376 (9750), p.1393-1400

6.
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wi...
by Reilly, Muredach P, Dr
The Lancet (British edition), 2011, Vol.377 (9763), p.383-392

7.
Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome
by Charchar, Fadi J, PhD
The Lancet (British edition), 2012, Vol.379 (9819), p.915-922

8.
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
by Mega, Jessica L, Dr
The Lancet (British edition), 2010, Vol.376 (9749), p.1312-1319

9.
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
by Talmud, Philippa J, Prof
The Lancet (British edition), 2013, Vol.381 (9874), p.1293-1301

10.
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
by Viney, Nicholas J, BSc
The Lancet (British edition), 2016, Vol.388 (10057), p.2239-2253

11.
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a...
by Fitzgerald, Kevin, Dr
The Lancet (British edition), 2014, Vol.383 (9911), p.60-68

12.
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial
by Ong, Kim-Thanh, MD
The Lancet (British edition), 2010, Vol.376 (9751), p.1476-1484

13.
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
by Roberts, Jason D, MD
The Lancet (British edition), 2012, Vol.379 (9827), p.1705-1711

14.
Genome-wide mapping of human loci for essential hypertension
by Caulfield, Mark
The Lancet (British edition), 2003-06-21, Vol.361 (9375), p.2118-2123

15.
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
by Raal, Frederick J, Prof
The Lancet (British edition), 2015, Vol.385 (9965), p.331-340

16.
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease
by Katsuya, T
The Lancet (British edition), 1995-06-24, Vol.345 (8965), p.1600-1603

17.
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
by Tsimikas, Sotirios, Prof
The Lancet (British edition), 2015, Vol.386 (10002), p.1472-1483

18.
Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome
by Behr, E
The Lancet (British edition), 2003-11-01, Vol.362 (9394), p.1457-1459

19.
Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study
by Kastelein, John J P, Prof
The Lancet (British edition), 2015, Vol.385 (9983), p.2153-2161

20.
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study
by Brown, David A
The Lancet (British edition), 2002-06-22, Vol.359 (9324), p.2159-2163
